Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the potential of pembrolizumab (Keytruda; Merck) to improve outcomes following head and neck ...

Researchers have developed an AI system that predicts brain tumor recurrence in children using sequential MRI scans. By ...

And it really has been a heartbreaking thing to watch from the original diagnosis to the revelation that brain surgery didn’t ...

Have you ever wondered whether the handedness of a surgeon may affect their ability to perform surgery? A new study ...